Doug Hampton

FORESEE PHARMACEUTICALS ANNOUNCES POSTER PRESENTATION AND PARTICIPATION AT THE WASOG 2023 INTERNATIONAL CONFERENCE ON SARCOIDOSIS AND INTERSTITIAL LUNG DISEASES (ILDs)

by

Poster on FP-020, a follow-on, best-in-class, oral MMP-12 inhibitor in a genetic model of sarcoidosis includes efficacy, biomarkers and complete translational cellular profiling supporting novel anti-inflammatory and anti-fibrotic mechanism TAIPEI, June 16, 2023 /PRNewswire/ — Foresee Pharmaceuticals (6576.TWO), (“Foresee”) announced today that the company will be participating and presenting a poster at the WASOG 2023 … Read more

Increasing Cases of Human Papillomavirus Diseases Drive Growth

by

DUBLIN, June 16, 2023 /PRNewswire/ — The “Human Papillomavirus Vaccine Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Valence (Bivalent, Quadrivalent, Nonvalent, Others), By Disease Indication, By Distribution Channel, By Company and By Region” report has been added to ResearchAndMarkets.com’s offering. The global human papillomavirus vaccine market is anticipated to observe … Read more

Cholesgen to enter into a drug discovery collaboration and licensing option agreement in hypercholesterolemia with AstraZeneca

by

SHANGHAI, June 16, 2023 /PRNewswire/ — Cholesgen (Shanghai) Co.Ltd. (‘Cholesgen’) today announced an exciting new collaboration to advance research and development in hypercholesterolemia and related metabolic diseases with AstraZeneca. This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint research effort will leverage complementary strengths and focus on selected targets … Read more

Cholesgen to enter into a drug discovery collaboration and licensing option agreement in hypercholesterolemia with AstraZeneca

by

SHANGHAI, June 16, 2023 /PRNewswire/ — Cholesgen (Shanghai) Co.Ltd. (‘Cholesgen’) today announced an exciting new collaboration to advance research and development in hypercholesterolemia and related metabolic diseases with AstraZeneca. This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint research effort will leverage complementary strengths and focus on selected targets … Read more

At L’Oustal high school, home help in the spotlight through an exhibition

by

the essential The L’Oustal high school is hosting an exhibition entitled “What talent!” until June 21. This exhibition is an educational, social and cultural innovation project that contributes to the promotion and attractiveness of the home help professions. Capucine de Decker is the organizer of the Pôle Culture et Santé Nouvelle Aquitaine, a structure at … Read more

Perceptions of 101 Professionals at Domestic, Chinese Innovative Biopharmaceutical Companies

by

DUBLIN, June 16, 2023 /PRNewswire/ — The “Chinese Biopharma, Clinical Development, CRO Utilization and Outlook 2023” report has been added to ResearchAndMarkets.com’s offering. This report takes a deep dive into the Chinese innovative biopharmaceutical market, providing groundbreaking insights into clinical development trends, activity, budget growth and preferences. The report also details clinical development outsourcing preferences and … Read more

Global Environmental Test Chambers Industry, Forecast to 2032

by

DUBLIN, June 16, 2023 /PRNewswire/ — The “Environmental Test Chamber: Global Markets” report has been added to ResearchAndMarkets.com’s offering. The global market for environmental test chambers was estimated to be $864.3 million in 2022. It is projected that the environmental test chamber market will grow at a CAGR of 2.5% and is forecast to reach $1.1 … Read more